Misoprostol ameliorates doxorubicin induced cardiac damage by decreasing oxidative stress and apoptosis in rats

References

• Abdel‑Daim MM, Kilany OE, Khalifa HA, Ahmed AAM. 2017. Allicin ameliorates doxorubicin‑induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemother Pharmacol. 80:745–753.
   PubMed Web of Science ®Google Scholar
• Aebi H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126.
   PubMed Web of Science ®Google Scholar
• Ascensao A, Magalhaes J, Soares JM, Ferreira R, Neuparth MJ, Marques F, Oliveira PJ, Duarte JA. 2005. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Heart Circ Physiol. 289:722–731.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Layton C, Suvarna S. 2013. Bancroft’s theory and practice of histological techniques. 7th ed. London, Edinburgh: Churchill Livingstone; p. 175–178.
   Google Scholar
• Chao HH, Liu JC, Hong HJ, Lin JW, Chen CH, Cheng TH. 2011. L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes. Int J Cardiol. 146:145–152.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen Y, Bi Y, Fu N, Shan C, Wang S, Aslam S, Wang PW, Xu J. 2007. Preventive cardioprotection of erythropoetin against doxorubicin-induced cardiomyopathy. Cardiovasc Drugs Ther. 21:367–374.
   PubMed Web of Science ®Google Scholar
• Colbay M, Yuksel S, Uslan I, Acarturk G, Karaman O, Bas O, Mollaoglu H, Yagmurca M, Ozen OA. 2010. Novel approach for the prevention of contrast nephropathy. Exp Toxicol Pathol. 62:81–89.
   PubMedGoogle Scholar
• Dash SK, Chattopadhyay S, Ghosh T, Dash SS, Tripathy S, Das B, Bag BG, Das D, Roy S. 2015. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-alpha-caspase-3 activity. Biomed Pharmacother. 72:144–157.
   PubMed Web of Science ®Google Scholar
• Draper HH, Hadley M. 1990. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 186:421–431.
   PubMed Web of Science ®Google Scholar
• Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77.
   PubMed Web of Science ®Google Scholar
• El-Refaiy AI. 2010. Histological and histochemical studies on the testis of albino rat under immobilization stress and the possible curative role of diazepam. J Egypt Ger Soc Zool. 60:1–22.
   Google Scholar
• Hadi N, Yousif NG, Al-amran FG, Huntei NK, Mohammad BI, Ali SJ. 2012. Vitamin E and telmisartan attenuates doxorubicin-induced cardiac injury in rat through down regulation of inflammatory response. BMC Cardiovasc Disord. 12:63–70.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zuo D, Li Z, Liu H, Dai Z, Cai J, Pang L, Wu Y. 2014. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway. Chem Pharm Bull. 62:45–53.
   PubMed Web of Science ®Google Scholar
• Kuroda J, Sadoshima J. 2010. NADPH oxidase 4 (Nox-4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA. 107:15565–15570.
   PubMed Web of Science ®Google Scholar
• Lin J, Fang L, Li H, Li Z, Lyu L, Wang H, Xiao J. 2019. Astragaloside IV alleviates doxorubicin-induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress. Eur J Pharmacol. 859:172490–172498.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang Y, Zheng D, Wei M, Xu H, Peng T. 2013. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Cardiovasc Res. 97:77–87.
   PubMed Web of Science ®Google Scholar
• Malhi H, Gores GJ. 2008. Cellular and molecular mechanisms of liver injury. Gastroenterology. 134:1641–1654.
   PubMed Web of Science ®Google Scholar
• Moongkarndi P, Srisawat C, Saetun P, Jantaravinid J, Peerapittayamongkol C, Soi-ampornkul R, Junnu S, Sinchaikul S, Chen S-T, Charoensilp P, Thongboonkerd V, Neungton N. 2010. Protective effect of mangosteen extract against β-amyloid-induced cytotoxicity, oxidative stress and altered proteome in SK-N-SH cells. J Proteome Res. 9:2076–2086.
   PubMed Web of Science ®Google Scholar
• Murrell DE, Denham JW, Harirforoosh S. 2015. Histopathology and oxidative stress analysis of concomitant misoprostol and celecoxib administration. J Toxicol Pathol. 28:165–170.
   PubMed Web of Science ®Google Scholar
• Nasr AY. 2013. Morphological, biochemical, histological, and ultrastructural protective effects of misoprostol on cisplatin induced-hepatotoxicity in adult male rats. Saud Med J. 34:1237–1247.
   PubMed Web of Science ®Google Scholar
• Nikitovic D, Juranek I, Wilks MF, Tzardi M, Tsatsakis A, Tzanakakis GN. 2014. Anthracycline-dependent cardiotoxicity and extracellular matrix remodeling. Chest. 146:1123–1130.
   PubMed Web of Science ®Google Scholar
• Octavia Y, Brunner-La Rocca HP, Moens AL. 2012a. NADPH oxidase dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach. Free Rad Biol Med. 52:291–297.
   PubMed Web of Science ®Google Scholar
• Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. 2012b. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 52:1213–1225.
   PubMed Web of Science ®Google Scholar
• Oliveira MS, Melo MB, Carvalho JL, Melo IM, Lavor MS, Gomes DA, de Goes AM, Melo MM. 2013. Doxorubicin cardiotoxicity and cardiac function improvement after stem cell therapy diagnosed by strain echocardiography. J Cancer Sci Ther. 5:42–52.
   Google Scholar
• Park HR, Ju EJ, Jo SK, Jung U, Kim SH, Yee ST. 2009. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer. 9:85–95.
   PubMed Web of Science ®Google Scholar
• Rajadurai M, Prince PSM. 2007. Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicology. 230:178–188.
   PubMed Web of Science ®Google Scholar
• Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C. 2011. Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation. J Pharmacol Exp Ther. 339:807–814.
   PubMed Web of Science ®Google Scholar
• Salam OM, Sleem AA, Omara EA, Hassan NS. 2009. Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride–induced hepatic damage in rats. Fund Clin Pharmacol. 23:179–188.
   PubMed Web of Science ®Google Scholar
• Shaker RA, Abboud SH, Assad HC, Hadi N. 2018. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. BMC Pharmacol Toxicol. 19:1–10.
   PubMed Web of Science ®Google Scholar
• Sostres C, Gargallo CJ, Arroyo MT, Lanas A. 2010. Adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 24:121–132.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clin Chem. 34:497–500.
   PubMed Web of Science ®Google Scholar
• Takemura G, Fujiwara H. 2007. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis. 49:330–352.
   PubMed Web of Science ®Google Scholar
• Tufekci O, Gunes D, Ozogul C, Kolatan E, Altun Z, Yilmaz O, Aktaş S, Erbayraktar Z, Kirkim G, Mutafoğlu K, Soylu A, Serbetçioğlu B, Güneri EA, Olgun N. 2009. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin nephrotoxicity. Chemotherapy. 55:451–459.
   PubMed Web of Science ®Google Scholar
• Tutun H, Ozmen O, Aktas I, Yalcın A, Turk A. 2019. Investigation of the effect of artemisinin on testis and kidney injury induced by doxorubicin. Acta Vet Beograd. 69:177–191.
   Web of Science ®Google Scholar
• Yagmurca M, Fadillioglu E, Erdogan H, Ucar M, Sogut S, Irmak MK. 2003. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res. 48:377–382.
   PubMed Web of Science ®Google Scholar